Quick Answer
GOLDENWELL BIOTECH, INC. reported Total Revenue of $139.00 for the year ending 2024.
- GOLDENWELL BIOTECH, INC. showed a decrease of -92.4% in Total Revenue from 2023 to 2024.
- This data is from GOLDENWELL BIOTECH, INC.'s annual report (Form 10-K), filed with the SEC on May 15, 2025.
- XBRL data for this metric is available from 2019 to 2024 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: $0.00 | Q1 2020: $0.00 | Q3 2020: $0.00 | Q3 2020: $0.00 | Q1 2021: $0.00 | Q1 2021: $0.00 | Q2 2021: $1.1 thousand | Q3 2021: $12.2 thousand | Q1 2022: $397.00 | Q2 2022: $3.7 thousand | Q3 2022: $43.7 thousand | Q4 2022: $0.00 | Q1 2023: $1.4 thousand | Q2 2023: $276.00 | Q3 2023: $382.00 | Q4 2023: $260.00 | Q1 2024: $158.00 | Q1 2024: $0.00 | Q2 2024: $139.00 | Q2 2024: $139.00 | Q3 2024: $0.00 | Q3 2024: $0.00 | Q1 2025: $0.00 | Q3 2025: $0.00.
- Historical annual values: Fiscal year 2024: $139.00 | Fiscal year 2023: $1.8 thousand | Fiscal year 2023: $2.3 thousand | Fiscal year 2022: $47.8 thousand | Fiscal year 2022: $47.8 thousand | Fiscal year 2021: $16.0 thousand | Fiscal year 2021: $16.0 thousand | Fiscal year 2020: $0.00 | Fiscal year 2020: $0.00 | Fiscal year 2019: $0.00.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: